As of April 25, 2021 the CDC and the U.S. Food and Drug Administration (FDA) recommend use of Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 Vaccine resume in the United States, after a temporary pause.
Read More ›The New Mexico Department of Health has announced the launch of a COVID-19 Exposure Notification System, NM Notify. When activated on a Smart Phone, the app alerts individuals when they have been exposed to someone who has verified that they are infected with COVID-19.
Read More ›The CDC and FDA have recommended a pause in the use of the Johnson & Johnson COVID-19 vaccine out of an abundance of caution after six reported U.S. cases (out of more than 6.8 million doses) of a rare and severe type of blood clot in individuals after receiving the J&J vaccine.
Read More ›On Friday, April 2, the Centers for Disease Control and Prevention (CDC) updated its travel guidance for fully vaccinated people to reflect the latest evidence and science. Given recent studies evaluating the real-world effects of vaccination, CDC recommends that fully vaccinated people can travel at low risk to themselves.
Read More ›New Mexico Department of Health (NMDOH) has announced that, as of Monday, April 5, 2021, all New Mexicans age 16 and older are now eligible for COVID-19 vaccine. NMDOH encourages all New Mexicans to register at vaccineNM.org
Read More ›The CDC released Interim Public Health Recommendations for Fully Vaccinated People. For the purposes of this guidance, people are considered fully vaccinated for COVID-19 2 weeks after they have received the second dose in a 2-dose series, or 2 weeks after they have received a single-dose vaccine. This guidance will be updated and expanded as more people become vaccinated and more information becomes available.
Read More ›